THE JORDANIAN PHARMACEUTICAL MANUFACTURING Financial
Trading Information
2019 | 2018 | 2017 | |
---|---|---|---|
Par Value/Share (JD) | 1.00 | 1.00 | 1.00 |
Closing Price (JD) | 0.27 | 0.49 | 0.44 |
Value Traded (JD) | 225,687 | 583,845 | 456,537 |
No. of Shares Traded | 632,989 | 1,527,080 | 954,311 |
No. of Transactions | 656 | 1,520 | 1,260 |
No. of Subscribed Shares | 25,312,500 | 25,312,500 | 25,312,500 |
Market Capitalization (JD) | 6,834,375 | 12,403,125 | 11,137,500 |
Fiscal Year Ended | 31/12/2019 | 31/12/2018 | 31/12/2017 |
Assets (JD)
2019 | 2018 | 2017 | |
---|---|---|---|
Cash on Hand & at Banks | 450,693 | 238,473 | 1,189,558 |
Accounts Receivable, Net | 13,292,348 | 20,930,467 | 15,508,103 |
Notes Receivable | 0 | 0 | 0 |
Post Dated Cheques | 743,295 | 703,790 | 1,105,443 |
Short Term Investments | 0 | 0 | 0 |
Inventory | 5,773,312 | 5,040,464 | 7,540,524 |
Spare Parts | 0 | 0 | 0 |
Total Current Assets | 21,763,400 | 27,428,765 | 26,252,775 |
Long Term Investments | 3,152,726 | 4,093,265 | 13,467,440 |
Fixed Assets, Net | 3,304,350 | 3,316,875 | 3,244,878 |
Lands | 490,127 | 490,127 | 490,127 |
Projects in Progress | 0 | 0 | 0 |
Total Fixed Assets | 3,794,477 | 3,807,002 | 3,735,005 |
Other Assets | 9,974,851 | 10,240,839 | 2,255,599 |
Total Assets | 38,685,454 | 45,569,871 | 45,710,819 |
Liabilities (JD)
2019 | 2018 | 2017 | |
---|---|---|---|
Accounts and Notes Payable | 11,782,192 | 11,542,391 | 9,197,469 |
Credit Banks | 949,830 | 707,156 | 673,281 |
Short Term Loans | 1,968,475 | 7,261,346 | 0 |
Accrued Part of Long Term Loans | 0 | 0 | 0 |
Total Current Liabilities | 15,308,346 | 20,079,503 | 16,782,606 |
Long Term Loans & Notes Payable | 11,954,500 | 5,067,524 | 5,266,062 |
Corporate Bonds | 0 | 0 | 0 |
Other Liabilities | 9,820,667 | 11,481,991 | 10,104,084 |
Total Liabilities | 37,083,513 | 36,629,018 | 32,152,752 |
Income Statement (JD)
2019 | 2018 | 2017 | |
---|---|---|---|
Operating Revenues | 9,977,197 | 22,205,163 | 27,488,192 |
Operating Expenses | 7,076,480 | 12,445,255 | 9,750,369 |
Gross Profit | 2,900,717 | 9,759,908 | 17,737,823 |
General and Administrative Expenses | 2,320,621 | 2,527,565 | 2,210,788 |
Selling and Distribution Expenses | 5,285,945 | 5,434,794 | 9,349,495 |
Depreciation (Period) | 740,631 | 643,028 | 1,672,349 |
Other Operating Expenses | 1,918,111 | 4,100,900 | 639,421 |
Net Operating Income | -6,623,960 | -2,303,351 | 5,538,119 |
Other Revenues | 2,033,120 | 135,305 | 4,156,356 |
Other Expenses | 169,061 | 93,956 | 6,565,018 |
Income Before Interest & Tax | -4,759,901 | -2,262,002 | 3,129,457 |
Interest Expenses | 1,147,462 | 1,800,182 | 1,357,028 |
Net Income Before Tax | -5,907,363 | -4,062,184 | 1,772,429 |
Income Tax (Period) | 6,563 | 51,293 | 123,148 |
Income Tax (Previous Years) | 0 | 0 | 735,783 |
Universities and Research Train Fees | 0 | 0 | 0 |
Board of Directors Remuniration | 0 | 0 | 45,000 |
Net Income | -5,913,926 | -4,113,477 | 868,498 |
Non-controlling Interest | -54,588 | -17,437 | -152,122 |
Net Income Pertains to Shareholders | -5,859,338 | -4,096,040 | 1,020,620 |
Cash Flow (JD)
2019 | 2018 | 2017 | |
---|---|---|---|
Cash Balance (Beginning) | -468,683 | 516,277 | 207,704 |
Net Cash Flow from (Used in) Operating Activities | -1,591,202 | -1,863,269 | 1,643,291 |
Net Cash Flow from (Used in) Investing Activities | -17,386 | -565,111 | -589,618 |
Net Cash Flow from (Used in) Financing Activities | 1,578,134 | 1,443,420 | -71,819 |
Cash Balance (Ending) | -499,137 | -468,683 | 1,189,558 |
Financial Ratios
2019 | 2018 | 2017 | |
---|---|---|---|
Turnover Ratio % | 2.501 | 6.033 | 3.770 |
Earning Per Share (JD) | -0.232 | -0.162 | 0.040 |
Dividend Per Share (JD) | 0.000 | 0.000 | 0.000 |
Book Value Per Share (JD) | 0.056 | 0.344 | 0.539 |
Price Earnings Ratio (Times) | -1.166 | -3.028 | 10.913 |
Dividend Yield % | 0.000 | 0.000 | 0.000 |
Dividend Per Share to Earning Per Share % | 0.000 | 0.000 | 0.000 |
Price to Book Value (Times) | 4.812 | 1.425 | 0.817 |
Gross Margin % | 29.074 | 43.953 | 64.529 |
Margin Before Interest and Tax % | -47.708 | -10.187 | 11.385 |
Profit Margin % | -59.274 | -18.525 | 3.160 |
Return On Assets % | -15.287 | -9.027 | 1.900 |
Return On Equity % | -412.570 | -47.058 | 7.484 |
Debt Ratio % | 95.859 | 80.380 | 70.340 |
Equity Ratio % | 4.141 | 19.620 | 29.661 |
Interest Coverage Ratio (Times) | -4.148 | -1.257 | 2.306 |
Total Assets Turnover (Times) | 0.258 | 0.487 | 0.601 |
Fixed Assets Turnover (Times) | 2.629 | 5.833 | 7.360 |
Working Capital Turnover (Times) | 1.546 | 3.021 | 2.903 |
Current Ratio (Times) | 1.422 | 1.366 | 1.564 |
Working Capital (JD) | 6,455,054.000 | 7,349,262.000 | 9,470,169.000 |